Fundraising Fox
VascVersa
Belfast, GB · 4 known investors
Find your way into VascVersa
Sign up to see every warm intro you have to VascVersa
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VascVersa team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.
Founders & leadership
Investors · 4
How we know: Clarendon Fund Managers Ltd.'s portfolio page · funding news · irishtimes.com · Not right? Tell us
How we know: the Companies House PSC register · funding news · irishtimes.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundAug 2022
Clarendon Fund Managers, Co-Fund NI, Innovation Investment Fund, QUBIS
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- VASCVERSA LTD
- Company number
- NI657918
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 20 Dec 2018
- Registered office
- 63 University Road, Belfast, Antrim, BT7 1NF
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2026 · next due 31 Dec 2027
- Confirmation statement
- last made up to 6 Jul 2026 · next due 20 Jul 2027
Current officers · 5
- Aidan Benedict Courtney — director, appointed 31 Mar 2021
- Reinhold Jaime Medina-Benavente — director, appointed 31 Mar 2021
- Christina Lisa O'Neill — director, appointed 20 Dec 2018
- Alan William Stitt — director, appointed 31 Mar 2021
- Qubis Ltd — corporate director, appointed 20 Dec 2018
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does VascVersa do?
- VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.
- Who founded VascVersa?
- VascVersa was founded by Professor Alan Stitt, Dr Christina O'Neill, Prof Reinhold Medina.
- Who are VascVersa's investors?
- VascVersa's investors include Clarendon Fund Managers Ltd., QUBIS.
- Where is VascVersa headquartered?
- VascVersa is headquartered in Belfast, GB.